← brief for 2026-08-16 · Slowing decline

Comparative effectiveness of finerenone versus steroidal mineralocorticoid receptor antagonists on sepsis-induced cardiomyopathy in patients with diabetic kidney disease: a real-world cohort study.

Article C Peer reviewed Observational

Key takeaways

In people with diabetic kidney disease, the drug finerenone was tied to a lower risk of heart trouble during severe infection (sepsis) than older steroid-based drugs of the same family. This looked back at records in a large health database, so it shows a link, not proof that the drug caused the benefit. It is an early signal that will need a real trial to confirm.

Who did this work

Wu JY · Lee KW · Huang SC · Chang HY · Lin YM

Source

Article · PubMed, the drug frontier · 2026 Jul 28
https://pubmed.ncbi.nlm.nih.gov/42582336/